The market is mainly driven by the significant applications of Pet Biopharmaceuticals in various end use industries. The expanding demands from the Prevention and Treatment, are propelling Pet Biopharmaceuticals market. Antiparasitic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological Products segment is estimated at % CAGR for the next seven-year period.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 47%.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pet Biopharmaceuticals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pet Biopharmaceuticals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Pet Biopharmaceuticals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pet Biopharmaceuticals sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Pet Biopharmaceuticals covered in this report include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc.

The global Pet Biopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Zoetis

Boehringer Ingelheim

Merck

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

Scope of Pet Biopharmaceuticals - Market Report

Report Metric	Details
Report Name	Pet Biopharmaceuticals - Market
Forecasted market size in 2029	US$ 19590 million
CAGR	4.7%
Forecasted years	2024 - 2029
Global Pet Biopharmaceuticals market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pet Biopharmaceuticals market, Segment by Type:	Antiparasitic Biological Products Antibacterial Others
Global Pet Biopharmaceuticals market, by Application	Prevention Treatment
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pet Biopharmaceuticals companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Pet Biopharmaceuticals - Market size in 2029?

Ans: The Pet Biopharmaceuticals - Market size in 2029 will be US$ 19590 million.

What is the Pet Biopharmaceuticals - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years.

What are the Application segmentation covered in the Pet Biopharmaceuticals - Market report?

Ans: The Applications covered in the Pet Biopharmaceuticals - Market report are Prevention, Treatment

What are the Type segmentation covered in the Pet Biopharmaceuticals - Market report?

Ans: The Types covered in the Pet Biopharmaceuticals - Market report are Antiparasitic, Biological Products, Antibacterial, Others

1 Market Overview of Pet Biopharmaceuticals

1.1 Pet Biopharmaceuticals Market Overview

1.1.1 Pet Biopharmaceuticals Product Scope

1.1.2 Pet Biopharmaceuticals Market Status and Outlook

1.2 Global Pet Biopharmaceuticals Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Pet Biopharmaceuticals Market Size by Region (2018-2029)

1.4 Global Pet Biopharmaceuticals Historic Market Size by Region (2018-2023)

1.5 Global Pet Biopharmaceuticals Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Pet Biopharmaceuticals Market Size (2018-2029)

1.6.1 North America Pet Biopharmaceuticals Market Size (2018-2029)

1.6.2 Europe Pet Biopharmaceuticals Market Size (2018-2029)

1.6.3 Asia-Pacific Pet Biopharmaceuticals Market Size (2018-2029)

1.6.4 Latin America Pet Biopharmaceuticals Market Size (2018-2029)

1.6.5 Middle East & Africa Pet Biopharmaceuticals Market Size (2018-2029)

2 Pet Biopharmaceuticals Market by Type

2.1 Introduction

2.1.1 Antiparasitic

2.1.2 Biological Products

2.1.3 Antibacterial

2.1.4 Others

2.2 Global Pet Biopharmaceuticals Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2018-2023)

2.2.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Pet Biopharmaceuticals Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Pet Biopharmaceuticals Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Pet Biopharmaceuticals Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Pet Biopharmaceuticals Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Pet Biopharmaceuticals Revenue Breakdown by Type (2018-2029)

3 Pet Biopharmaceuticals Market Overview by Application

3.1 Introduction

3.1.1 Prevention

3.1.2 Treatment

3.2 Global Pet Biopharmaceuticals Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2018-2023)

3.2.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Pet Biopharmaceuticals Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Pet Biopharmaceuticals Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Pet Biopharmaceuticals Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Pet Biopharmaceuticals Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Pet Biopharmaceuticals Revenue Breakdown by Application (2018-2029)

4 Pet Biopharmaceuticals Competition Analysis by Players

4.1 Global Pet Biopharmaceuticals Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)

4.3 Date of Key Players Enter into Pet Biopharmaceuticals Market

4.4 Global Top Players Pet Biopharmaceuticals Headquarters and Area Served

4.5 Key Players Pet Biopharmaceuticals Product Solution and Service

4.6 Competitive Status

4.6.1 Pet Biopharmaceuticals Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Zoetis

5.1.1 Zoetis Profile

5.1.2 Zoetis Main Business

5.1.3 Zoetis Pet Biopharmaceuticals Products, Services and Solutions

5.1.4 Zoetis Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.1.5 Zoetis Recent Developments

5.2 Boehringer Ingelheim

5.2.1 Boehringer Ingelheim Profile

5.2.2 Boehringer Ingelheim Main Business

5.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Products, Services and Solutions

5.2.4 Boehringer Ingelheim Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.2.5 Boehringer Ingelheim Recent Developments

5.3 Merck

5.3.1 Merck Profile

5.3.2 Merck Main Business

5.3.3 Merck Pet Biopharmaceuticals Products, Services and Solutions

5.3.4 Merck Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.3.5 Elanco Recent Developments

5.4 Elanco

5.4.1 Elanco Profile

5.4.2 Elanco Main Business

5.4.3 Elanco Pet Biopharmaceuticals Products, Services and Solutions

5.4.4 Elanco Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.4.5 Elanco Recent Developments

5.5 Virbac

5.5.1 Virbac Profile

5.5.2 Virbac Main Business

5.5.3 Virbac Pet Biopharmaceuticals Products, Services and Solutions

5.5.4 Virbac Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.5.5 Virbac Recent Developments

5.6 Dechra Veterinary Products

5.6.1 Dechra Veterinary Products Profile

5.6.2 Dechra Veterinary Products Main Business

5.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Products, Services and Solutions

5.6.4 Dechra Veterinary Products Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.6.5 Dechra Veterinary Products Recent Developments

5.7 Ceva

5.7.1 Ceva Profile

5.7.2 Ceva Main Business

5.7.3 Ceva Pet Biopharmaceuticals Products, Services and Solutions

5.7.4 Ceva Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.7.5 Ceva Recent Developments

5.8 Vetoquinol

5.8.1 Vetoquinol Profile

5.8.2 Vetoquinol Main Business

5.8.3 Vetoquinol Pet Biopharmaceuticals Products, Services and Solutions

5.8.4 Vetoquinol Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.8.5 Vetoquinol Recent Developments

5.9 Ouro Fino Saude

5.9.1 Ouro Fino Saude Profile

5.9.2 Ouro Fino Saude Main Business

5.9.3 Ouro Fino Saude Pet Biopharmaceuticals Products, Services and Solutions

5.9.4 Ouro Fino Saude Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.9.5 Ouro Fino Saude Recent Developments

5.10 Norbrook

5.10.1 Norbrook Profile

5.10.2 Norbrook Main Business

5.10.3 Norbrook Pet Biopharmaceuticals Products, Services and Solutions

5.10.4 Norbrook Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.10.5 Norbrook Recent Developments

5.11 Jindun

5.11.1 Jindun Profile

5.11.2 Jindun Main Business

5.11.3 Jindun Pet Biopharmaceuticals Products, Services and Solutions

5.11.4 Jindun Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.11.5 Jindun Recent Developments

5.12 Chopperlvya Animal Health

5.12.1 Chopperlvya Animal Health Profile

5.12.2 Chopperlvya Animal Health Main Business

5.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Products, Services and Solutions

5.12.4 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.12.5 Chopperlvya Animal Health Recent Developments

5.13 CAHIC

5.13.1 CAHIC Profile

5.13.2 CAHIC Main Business

5.13.3 CAHIC Pet Biopharmaceuticals Products, Services and Solutions

5.13.4 CAHIC Pet Biopharmaceuticals Revenue (US$ Million) & (2018-2023)

5.13.5 CAHIC Recent Developments

6 North America

6.1 North America Pet Biopharmaceuticals Market Size by Country (2018-2029)

6.2 United States

6.3 Canada

7 Europe

7.1 Europe Pet Biopharmaceuticals Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Pet Biopharmaceuticals Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Pet Biopharmaceuticals Market Dynamics

11.1 Pet Biopharmaceuticals Industry Trends

11.2 Pet Biopharmaceuticals Market Drivers

11.3 Pet Biopharmaceuticals Market Challenges

11.4 Pet Biopharmaceuticals Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Dechra Veterinary Products

Chopperlvya Animal Health

CAHIC

List of Tables

Table 1. Global Market Pet Biopharmaceuticals Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Pet Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Pet Biopharmaceuticals Market Size Share by Region (2018-2023)

Table 4. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Pet Biopharmaceuticals Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Pet Biopharmaceuticals Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Pet Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Pet Biopharmaceuticals Revenue Market Share by Type (2018-2023)

Table 9. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Pet Biopharmaceuticals Revenue Market Share by Type (2024-2029)

Table 11. North America Pet Biopharmaceuticals Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Pet Biopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Pet Biopharmaceuticals Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Pet Biopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Pet Biopharmaceuticals Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Pet Biopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Pet Biopharmaceuticals Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Pet Biopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Pet Biopharmaceuticals Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Pet Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Pet Biopharmaceuticals Revenue Market Share by Application (2018-2023)

Table 24. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Pet Biopharmaceuticals Revenue Market Share by Application (2024-2029)

Table 26. North America Pet Biopharmaceuticals Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Pet Biopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Pet Biopharmaceuticals Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Pet Biopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Pet Biopharmaceuticals Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Pet Biopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Pet Biopharmaceuticals Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Pet Biopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Pet Biopharmaceuticals Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Pet Biopharmaceuticals Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)

Table 39. Date of Key Players Enter into Pet Biopharmaceuticals Market

Table 40. Global Pet Biopharmaceuticals Key Players Headquarters and Area Served

Table 41. Pet Biopharmaceuticals Product Solution and Service

Table 42. Global Pet Biopharmaceuticals Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Zoetis Basic Information List

Table 45. Zoetis Description and Business Overview

Table 46. Zoetis Pet Biopharmaceuticals Products, Services and Solutions

Table 47. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Zoetis (2018-2023)

Table 48. Zoetis Recent Developments

Table 49. Boehringer Ingelheim Basic Information List

Table 50. Boehringer Ingelheim Description and Business Overview

Table 51. Boehringer Ingelheim Pet Biopharmaceuticals Products, Services and Solutions

Table 52. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Boehringer Ingelheim (2018-2023)

Table 53. Boehringer Ingelheim Recent Developments

Table 54. Merck Basic Information List

Table 55. Merck Description and Business Overview

Table 56. Merck Pet Biopharmaceuticals Products, Services and Solutions

Table 57. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Merck (2018-2023)

Table 58. Merck Recent Developments

Table 59. Elanco Basic Information List

Table 60. Elanco Description and Business Overview

Table 61. Elanco Pet Biopharmaceuticals Products, Services and Solutions

Table 62. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Elanco (2018-2023)

Table 63. Elanco Recent Developments

Table 64. Virbac Basic Information List

Table 65. Virbac Description and Business Overview

Table 66. Virbac Pet Biopharmaceuticals Products, Services and Solutions

Table 67. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Virbac (2018-2023)

Table 68. Virbac Recent Developments

Table 69. Dechra Veterinary Products Basic Information List

Table 70. Dechra Veterinary Products Description and Business Overview

Table 71. Dechra Veterinary Products Pet Biopharmaceuticals Products, Services and Solutions

Table 72. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Dechra Veterinary Products (2018-2023)

Table 73. Dechra Veterinary Products Recent Developments

Table 74. Ceva Basic Information List

Table 75. Ceva Description and Business Overview

Table 76. Ceva Pet Biopharmaceuticals Products, Services and Solutions

Table 77. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Ceva (2018-2023)

Table 78. Ceva Recent Developments

Table 79. Vetoquinol Basic Information List

Table 80. Vetoquinol Description and Business Overview

Table 81. Vetoquinol Pet Biopharmaceuticals Products, Services and Solutions

Table 82. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Vetoquinol (2018-2023)

Table 83. Vetoquinol Recent Developments

Table 84. Ouro Fino Saude Basic Information List

Table 85. Ouro Fino Saude Description and Business Overview

Table 86. Ouro Fino Saude Pet Biopharmaceuticals Products, Services and Solutions

Table 87. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Ouro Fino Saude (2018-2023)

Table 88. Ouro Fino Saude Recent Developments

Table 89. Norbrook Basic Information List

Table 90. Norbrook Description and Business Overview

Table 91. Norbrook Pet Biopharmaceuticals Products, Services and Solutions

Table 92. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Norbrook (2018-2023)

Table 93. Norbrook Recent Developments

Table 94. Jindun Basic Information List

Table 95. Jindun Description and Business Overview

Table 96. Jindun Pet Biopharmaceuticals Products, Services and Solutions

Table 97. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Jindun (2018-2023)

Table 98. Jindun Recent Developments

Table 99. Chopperlvya Animal Health Basic Information List

Table 100. Chopperlvya Animal Health Description and Business Overview

Table 101. Chopperlvya Animal Health Pet Biopharmaceuticals Products, Services and Solutions

Table 102. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Chopperlvya Animal Health (2018-2023)

Table 103. Chopperlvya Animal Health Recent Developments

Table 104. CAHIC Basic Information List

Table 105. CAHIC Description and Business Overview

Table 106. CAHIC Pet Biopharmaceuticals Products, Services and Solutions

Table 107. Revenue (US$ Million) in Pet Biopharmaceuticals Business of CAHIC (2018-2023)

Table 108. CAHIC Recent Developments

Table 109. North America Pet Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 110. North America Pet Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 111. Europe Pet Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 112. Europe Pet Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 113. Asia-Pacific Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 114. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)

Table 115. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)

Table 116. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2018-2023)

Table 117. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2024-2029)

Table 118. Latin America Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 119. Latin America Pet Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 120. Latin America Pet Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 121. Middle East & Africa Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 122. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 123. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 124. Pet Biopharmaceuticals Market Trends

Table 125. Pet Biopharmaceuticals Market Drivers

Table 126. Pet Biopharmaceuticals Market Challenges

Table 127. Pet Biopharmaceuticals Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pet Biopharmaceuticals Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Pet Biopharmaceuticals Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Pet Biopharmaceuticals Market Share by Regions: 2022 VS 2029

Figure 4. Global Pet Biopharmaceuticals Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Pet Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Pet Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Pet Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Pet Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Pet Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Antiparasitic

Figure 11. Global Antiparasitic Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Biological Products

Figure 13. Global Biological Products Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Antibacterial

Figure 15. Global Antibacterial Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Others

Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Global Pet Biopharmaceuticals Market Size Share by Type: 2022 & 2029

Figure 19. North America Pet Biopharmaceuticals Revenue Market Share by Type (2018-2029)

Figure 20. Europe Pet Biopharmaceuticals Revenue Market Share by Type (2018-2029)

Figure 21. Asia-Pacific Pet Biopharmaceuticals Revenue Market Share by Type (2018-2029)

Figure 22. Latin America Pet Biopharmaceuticals Revenue Market Share by Type (2018-2029)

Figure 23. Middle East and Africa Pet Biopharmaceuticals Revenue Market Share by Type (2018-2029)

Figure 24. Prevention Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Global Pet Biopharmaceuticals Market Size Share by Application: 2022 & 2029

Figure 27. North America Pet Biopharmaceuticals Revenue Market Share by Application (2018-2029)

Figure 28. Europe Pet Biopharmaceuticals Revenue Market Share by Application (2018-2029)

Figure 29. Asia-Pacific Pet Biopharmaceuticals Revenue Market Share by Application (2018-2029)

Figure 30. Latin America Pet Biopharmaceuticals Revenue Market Share by Application (2018-2029)

Figure 31. Middle East and Africa Pet Biopharmaceuticals Revenue Market Share by Application (2018-2029)

Figure 32. Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 33. Global Top 5 and Top 10 Players Pet Biopharmaceuticals Market Share in 2022

Figure 34. North America Pet Biopharmaceuticals Market Share by Country (2018-2029)

Figure 35. United States Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 36. Canada Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 37. Germany Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 38. France Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 39. U.K. Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 40. Italy Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 41. Russia Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 42. Nordic Countries Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 43. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2018-2029)

Figure 44. China Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 45. Japan Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 46. South Korea Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 47. Southeast Asia Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 48. India Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 49. Australia Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 50. Latin America Pet Biopharmaceuticals Market Share by Country (2018-2029)

Figure 51. Mexico Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 52. Brazil Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 53. Middle East & Africa Pet Biopharmaceuticals Market Share by Country (2018-2029)

Figure 54. Turkey Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 56. UAE Pet Biopharmaceuticals Market Size (2018-2029) & (US$ Million)

Figure 57. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions